FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images The…

Healthy Returns: Novo Nordisk’s Ozempic faces scrutiny over potential link to rare eye condition

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared…